Admission Values of D-dimer and C-reactive Protein (CRP) Predict the Long-term Outcomes in Acute Aortic Dissection

Kentaro Mori1, Hidetaka Tamune, Hiroyuki Tanaka

  • 1Department of Emergency Rescue, Tokyo Metropolitan Tama Medical Center, Japan.

Insights

Admission D-dimer and C-reactive protein (CRP) can predict long-term outcomes in acute aortic dissection (AAD). Elevated admission D-dimer is a valuable marker for predicting both short-term and long-term AAD prognosis.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Biomarkers

Background:

  • Acute aortic dissection (AAD) is a life-threatening condition.
  • Admission D-dimer and C-reactive protein (CRP) are known short-term outcome predictors in AAD.
  • Long-term outcome prediction using these biomarkers remains under-investigated.

Purpose of the Study:

  • To investigate the association between admission D-dimer and C-reactive protein (CRP) levels and long-term outcomes in patients with acute aortic dissection (AAD).
  • To determine optimal cut-off values for these biomarkers in predicting adverse events.

Main Methods:

  • Retrospective analysis of 173 AAD patients hospitalized between 2005 and 2013.
  • Receiver operating characteristic (ROC) analysis to determine optimal biomarker cut-off levels.
  • Multiple Cox regression analysis to assess hazard ratios for long-term adverse events.

Main Results:

  • Admission D-dimer levels showed a hazard ratio of 3.4 (95% CI 1.5-7.3, p=0.004) for adverse outcomes.
  • Admission CRP levels showed a hazard ratio of 2.7 (95% CI 1.2-5.5, p=0.014) for adverse outcomes.
  • Both biomarkers demonstrated predictive value for long-term prognosis.

Conclusions:

  • Admission D-dimer and CRP levels are significant predictors of long-term outcomes in AAD patients.
  • Admission D-dimer is a valuable marker for predicting both short-term and long-term prognosis in AAD.
  • These findings support the use of baseline D-dimer and CRP in risk stratification for AAD.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
794
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
710
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
384
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
936
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.1K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K